EVALUATION OF WOMEN FOLLOWING HYSTERECTOMY WITH AND WITHOUT CONSERVATION OF OVARIES

Similar documents
Menopause & HRT. Matt McKenna Elliot Davis

Post-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018

PERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.

25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy?

Hysterectomy with Preservation of both Ovaries does not Result in Premature Ovarian Failure

Premature Menopause : Diagnosis and Management

Long-Term Health Outcomes of Surgical Menopause

A survey on the histopathologic findings in 636 cases of hysterectomy: A sonographic assessment study

Research. Breast cancer represents a major

Menopause and HRT. John Smiddy and Alistair Ledsam

06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence:

Hysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy?

Menopause & HRT. Rosie & Alex. Image:

BSO, HRT, and ERT. No relevant financial disclosures

Hysterectomy Fact versus fiction. Richard Dover Specialist Gynaecologist

Surgery to Reduce the Risk of Ovarian Cancer. Information for Women at Increased Risk

CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology

Is It Time To Implement Ovarian Cancer Screening?

One of the commonest gynecological cancers,especially in white Americans.

International Journal of Research and Review E-ISSN: ; P-ISSN:

Clinical Study Laparoscopic Surgery in Elderly Patients Aged 65 Years and Older with Gynecologic Disease

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

Menopause Symptoms and Management: After Breast Cancer

Hormones friend or foe? Undertreatment and quality of life. No conflicts of interest to declare

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

Dr. Mojibian. Menopause

Surgery to reduce the risk of ovarian cancer

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 73/ Sept 10, 2015 Page 12639

Department of Obstetrics and Gynecology, Osaka Medical College, Takatsuki-city, Osaka , Japan. Pituitary gonadotropin, Clinical managament

Northeast Ohio Urogynecology Patient History Intake Form. Last Name First Name Age. Date of Birth Race Referring Physician.

Use of Ovarian Suppression and Ablation in Breast Cancer Treatment

The Adolescent: A Patient at Risk: Ovarian Failure in Adolescent Cancer Survivors

Ovaries: In Sickness and Health. Mr N Pisal Consultant Gynaecologist The Portland Hospital

Bangladesh Journal of Medical Science Vol. 15 No. 03 July 16

Spectrum of gynecological disorders in elderly women

Gynaecology Cancer Red Flags. Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017

SOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer

Histopathological Study of Hysterectomy Operations in A University Clinic in Tehran From 2005 to 2009

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Cervical Cancer - Suspected

Gynecologic Decision Making Based on Sonographic Findings

Physiology of Menopause

Chapter 4. Managing Fertility in Childhood Cancer Patients T.K. Woodruff and K.A. Snyder (eds.) Oncofertility. Springer 2007

Original Policy Date

Leslie R. Schover, PhD Department of Behavioral Science

Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy*

ARIC STUDY MANUSCRIPT PROPOSAL # 714. PC Reviewed: 03/07/00 Status: Deferred Priority: SC Reviewed: Status: Priority:

Women s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School

University Gynecologic Oncology Associates

Managing menopause in Primary Care and recent advances in HRT

The Centre for Reproductive Medicine HYSTERECTOMY

AusPharm CE Hormone therapy 23/09/10. Hormone therapy

North American Menopause Society (NAMS)

Hormone replacement therapy and breast density after surgical menopause

A Practitioner s Toolkit for the Management of the Menopause

A Prospective Observational Study to Evaluate the Efficacy and Safety Profiles of Leuprorelin 3 Month Depot for the Treatment of Pelvic Endometriosis

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories

Clinico- Pathological Correlation of Abdominal Hysterectomy Specimens

ORIGINAL ARTICLE CLINICO-PATHOLOGICAL CORRELATION OF HYSTERECTOMY SPECIMENS FOR ABNORMAL UTERINE BLEEDING IN RURAL AREA

Epidemiology of epithelial ovarian cancer: a tertiary hospital based study in Goa, India

Laparoscopic Hysterectomy

2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK

Risk-reducing surgery and hormones

Hormonal Control of Human Reproduction

MENOPAUSE. I have no disclosures 10/11/18 OBJECTIVES WHAT S NEW? WHAT S SAFE?

What s New in Menopause Management. Objectives

Index. Note: Page numbers of article titles are in boldface type.

Appendix: Reference Table of HT Brand Names

Introduction to GYN Specialties

Research Article The Treatment with Hormone Replacement Therapy and Phytoestrogens and The Evolution of Urogenital Symptoms in Postmenopausal Women

Are changes in sexual functioning during midlife due to aging or menopause?

UTERINE LEIOMYOSARCOMA. About Uterine leiomyosarcoma

US Imaging of pelvic congestion syndrome

Female Sexual Hormones Indications and Therapy

Menopause Matters. Equity Office Staff Seminar 14 November 2018

Inherited Ovarian Cancer Diagnosis and Prevention

Endometriosis. What you need to know. 139 Dumaresq Street Campbelltown Phone Fax

SPECIAL CONTRIBUTION. Executive summary: Stages of Reproductive Aging Workshop (STRAW) BACKGROUND AND SIGNIFICANCE

Charles E. Stoopack M.D. FACOG

Question Bank III - BHMS

Use of vaginal estrogen in Danish women: a nationwide cross-sectional study

Squamous cell carcinoma arising in a dermoid cyst of the ovary: a case series

MENOPAUSAL HORMONE THERAPY 2016

HRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College

Ovarian preservation with lateral ovarian transposition in operable Ca cervix: experience at a tertiary care center

Hormone therapy. Where are we now? Menopause. Menopause symptoms. Background. Objective. Discussion. Keywords: menopause; hormone therapy

Orals,Transdermals, and Other Estrogens in the Perimenopause

Labrix Clinical Services, Inc.

Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine

Executive summary: Stages of Reproductive Aging Workshop (STRAW)

CY Tse, AMK Chow, SCS Chan. Introduction

COMPARATION AMONG THE MAIN HYSTERECTOMY ROUTES

Primary Care Gynaecology Guidelines: HEAVY REGULAR MENSTRUAL BLEEDING

Menopause management NICE Implementation

Results of implication of aromatase inhibitors in therapy of genital endometriosis Yarmolinskaya M. (Speaker), Bezhenar V., Molotkov A.

Endocrinology of the Female Reproductive Axis

Arvind Vashisht MD MRCOG

CLEAR COVERAGE HYSTERECTOMY CHECKLISTS

Community Gynaecology. Top Tips for GPs

Transcription:

Int. J. Chem. Sci.: 6(3), 2008, 1228-1235 EVALUATION OF WOMEN FOLLOWING HYSTERECTOMY WITH AND WITHOUT CONSERVATION OF OVARIES RAMPRASAD DEY, SUBHASH CHANDRA BISWAS, RANU ROY BISWAS a and ARUNIMA MUKHOPADHYAY b Department of Gynaecology & Obstetrics, IPGMER & SSKM Hospital, KOLKATA 700020 (W. B.) INDIA a Department of Pathology, Calcutta National Medical College & Hospital, b ESI Hospital, KALYANI (W. B.) INDIA ABSTRACT The onset and nature of different postmenopausal symptoms and hormonal status in women following hysterectomy with and without conservation of ovaries has been studied. Forty patients aged 35-50 years, who had undergone hysterectomy (abdominal or vaginal) for benign indications, within last five years were selected. 20 patients had undergone hysterectomy with bilateral salpingo-oophorectomy (BSO) and the rest 50% had undergone hysterectomy with conservation of both ovaries. These two groups of women were followed up by clinical symptoms (vasomotor, urogenital, psychological), hormonal evaluation (serum FSH, LH and estradiol) and measurement of bone density. 50% of the patients became symptomatic (vasomotor) within one year following hysterectomy with BSO whereas 40% within there to five years in the ovarian conservation group. Psychological symptoms developed in 25% cases in hysterectomy with BSO group and 20% cases in ovarian conservation group but genitourinary symptoms developed in 25% cases in both the groups. There was acute rise of both FSH and LH in hysterectomy with BSO group within one year of operation but in ovarian conservation group, FSH and LH started to rise after one year of operation. It was reverse in case of estradiol. Bone densitometry showed osteoporosis in 30% hysterectomised women with BSO whereas in 25% of women in ovarian conservation group. From the present study, it is clearly evident that most of the menopausal symptoms and hormonal changes developed earlier in hysterectomy with BSO group but gradually the scenario become almost same in both the groups of hysterectomy within there to five years of operation. So basically the clinical, metabolic and hormonal milieu assume the same status in both the groups within three to five years of operation. Author for correspondence; 836 Block-P, New Alipore, Kolkata 700053 (W. B.) INDIA Phone-033-24003998; 09433219808; E-mail. Ram_arunima@yahoo.co.in

Int. J. Chem. Sci.: 6(3), 2008 1229 Key words: Hysterectomy, Ovarian conservation, Menopausal symptoms. INTRODUCTION Hysterectomy is the second most common major operation after caesarean section 1 in the field of Obstetrics & Gynaecology. Following hysterectomy women enter into the phase of menopause. Menopause is derived from the Greek word Men (month) and Pauo (to stop) i. e. cessation of menstruation natural or iatrogenic. Women are regarded as postmenopausal only if they had experienced estrogen defficiency symptoms, amenorrhoeic for more than six months and serum F.S.H. greater than 40 iu / L. Objectives (i) (ii) The aims of the present study were To compare the date of onset and varied presentations of different postmenopausal symptomatology and behavioural patterns in women following hysterectomy with and without conservation of ovaries. To find out hormonal, biochemical and metabolic status between these two groups of women and (iii) To note the ovarian function after hysterectomy, where ovaries were preserved. Materials and methods EXPERIMENTAL The study was conducted in the Department of Gynaecology & Obstetrics, Calcutta National Medical & Hospital. Forty patients aged between 35 to 50 years, who had undergone hysterectomy either abdominally or vaginally, were selected from indoor admission & follow up clinics of out patient department. Indications of operation were leiomyomas, genital prolapse, dysfunctional uterine bleeding (DUB) and endometriosis. Equal number of age-matched women (20 patients in each group), who had undergone hysterectomy with bilateral salpingo-oophorectomy (Group A) and with conservation of both ovaries (Group B), were recruited for the study.. All the women, who had irregular menstruation before operation, genital malignancy and co-existent any other significant medical disease like diabetes, hypertension, and endocrine disorders were excluded from the study. Patients who had undergone hysterectomy within five years and were not under any hormone replacement therapy (HRT) are included in this study. These two groups of women were followed up to note clinical parameters of menopausal symptoms like

1230 Ramprasad Dey et al.: Evaluation of Women. vasomotor, urogenital, psychological, and symptoms of osteoporosis; and to evaluate hormonal status (serum FSH, LH and estradiol ). Measurement of bone density and ultrasonic evaluation of conserved ovaries were also performed. Results were analyzed and compared. RESULTS AND DISCUSSION 50% (10 out of 20) of the patients in Group A, following hysterectomy with bilateral salpingo-oophorectomy (BSO) develops postmenopausal symptoms compared to 40% of the patients in Group B, with conserved ovaries. Table 1.Total number of cases and its distribution in different age groups Groups of patients Group A (with BSO) Group B (with OVC) No of cases (Percentage) 35-40 years 41-45 years 46-50 years 20 (50%) 5 7 8 20 (50%) 12 4 4 BSO = Hystrerctomy with bilateral salpingo-oophorectomy OVC = Hysterectomy with conservation of both the ovaries. Table 2. Study of symptomatic patients in relation to duration of hysterectomy Groups Group A with BSO* Group B without BSO** *Bilatertal salpingo-oophorectomy **Conserved ovaries 0-1 years 1-3 years 3-5 years Total patients symptomatic N % N % N % N % 6 50 3 75 1 25 10 50 3 25 2 50 3 75 8 40

Int. J. Chem. Sci.: 6(3), 2008 1231 Table 3. Comparison of different types of symptoms between two groups Symptoms Group A Group B Vasomotor 50% 40% Genitourinary 25% 25% Psychological 25% 20% Osteoporosis 30% 25% Table 4. Distribution of cases according to symptoms in different age groups in different types of hysterectomy Hysterectomy with BSO Symptoms No. of patients in different age groups 35-40 years 41-45 years 46-50 years Total (%) 5 7 8 20 Vasomotor 4 3 3 10 (50%) Genitourinary - 2 3 5 (25%) Psychological 3 1 1 5 (25%) Osteoporosis 1 1 4 6 (30%) Hysterectomy with OVC Symptoms No. of patients in different age groups 35-40 years 41-45 years 46-50 years Total (%) 12 4 4 20 Vasomotor 5 2 1 8 (40 %) Genitourinary - 2 3 5 (25 %) Psychological 2 1 1 4 (20 %) Osteoporosis - 2 3 5 (25 %)

1232 Ramprasad Dey et al.: Evaluation of Women. Table 5. Study of hormonal profiles between these two groups Hormones F.S.H. (IU/L) L.H. (IU/L) Estrdiol (pg/ml) Years after Mean value in operation Group A Group B 0-1 year 50.4 16.2 1-3 year 62.5 35.6 3-5 year 75.6 69.2 0-1 year 48.8 20.4 1-3 year 65.4 37.5 3-5 year 79.8 65.5 0-1 year 15.4 80.8 1-3 year 12.5 50.3 3-5 year 12.2 15.5 Table 6. Bone densitometric study of the patients Groups Total patients Normal (0 to -1 S.D.) Osteopenic (-1 to -2.5 S.D.) Osteoporosis (< - 2.5 S.D.) Group A 20 11 (55 %) 3 (15 %) 6 (30 %) Group B 20 13 (65 %) 2 (10 %) 5 (25 %) Maximum number of the patients became symptomatic within one year following hysterectomy with BSO whereas the women of ovarian conservation group took three to five years following operation to experience the symptoms. In both the groups, vasomotor symptoms, mainly hot flush, was the most common symptom. It developed in younger patients (35-40 years of age) but severity of symptoms were much less in Group B. Psychological symptoms developed in 25% cases in Group A and 20 % cases in Group B but genitourinary symptoms developed in 25% cases of both the groups. There was significant difference in FSH, LH and estradiol between these two groups within one year of operation. There was acute rise of both FSH and LH in hysterectomy with BSO group within one year of operation but in Group B, FSH and LH started to rise after one year of operation. Interestingly, within three to five years, the hormonal levels became almost equal in both the groups. In hysterectomy with BSO group, mean FSH and LH within one

Int. J. Chem. Sci.: 6(3), 2008 1233 year of operation were 50.4 I.U./L and 48.8 I.U./L, respectively where as in hysterectomy with ovarian conservation group, these were 16.2 I.U./L and 20.4 I.U./L. In the former group, there was a sharp fall of estradiol (15.4 pg /ml) within one year of operation but in the latter group estradiol (80.8 pg/ml) was within normal limit during this period. Bone densitometric study showed in group A, 55% of subjects were normal, 15% osteopenic and 30% osteoporotic whereas in group B, 65% normal,10% osteopenic and 25% osteoporotic. USG study of conserved ovaries failed to extract any conclusive data. 50% of the patients were symptomatic following hysterectomy with BSO whereas 40% of the patients were symptomatic in the ovarian conservation group. According to Askel et al. 2 immediate symptoms specially hot flushes occurred in 37-50% of cases following bilateral oophorectomy in premenopausal women, which is in accordance with our study. But Defazio et al. 3 documented 76% cases of menopausal symptoms after oophorectomy. In present study, most common symptom was hot flush which is also in accordance with several studies done by Thomson et al., Hammer et al. and Richards 4. In our study, psychological symptoms developed in 25% cases in hysterectomy with BSO group and 20 % cases in ovarian conservation group. The study done by Martin et al. 5 showing the incidence of depression was higher after bilateral oophorectomy than hysterectomy with ovarian conservation. The study of Perlstein 6 showed that in the absence of adequate HRT, simultaneous bilateral oophorectomy enhanced depression though in some reports (Ryan et al. 7 ), concurrent bilateral oophorectomy has shown no increase in depression when compared to hysterectomy. The longitudinal study of premenopausal women was done by Everson et al., 8 which indicated that hysterectomy with or without oophorectomy was not associated with a negative psychological impact among middle aged women. At present, no firm data support the view that natural menopause cause depression. In this study, genitourinary symptoms, mostly affecting aged persons developed in 25% of cases in both the groups. The study of Greendale et al. 9 showed that 10-40% of all postmenopausal women had urogenital symptoms. Another study done by Van Geelen et al. 10 showed that 27% women complained of vaginal dryness, soreness and dyspareunia where as 36% complained of urinary symptoms such as leakage and recurrent infections. In group A, mean FSH and LH within one year of operation were 50.4 I.U./L and 48.8 I.U./L, respectively where as in Group B, these were 16.2 I.U./L and 20.4 I.U./L. The

1234 Ramprasad Dey et al.: Evaluation of Women. difference gradually decreased and within three to five years, the hormone levels of these two groups became almost equal. In group A, there was a sharp fall of estradiol (15.4 pg /ml ) within one year of operation but in group B, estradiol ( 80.8 pg/ml) was within normal limit during this period. Within three to five years of operation, estradiol level in ovarian conservation group became almost equal to that in hysterectomy with BSO group. Laughlin et al. 11 also showed that in women, who had undergone hysterectomy with bilateral oophorectomy, total estradiol levels tend to be lower but oophorectomy status did not affect levels of bioavailable estradiol, estrone, or SHBG. CONCLUSION From the study, it is clearly evident that most of the menopausal symptoms developed earlier with marginally greater frequency and comparatively greater severity in hysterectomy with BSO group during immediate post-operative follow up periods but gradually the clinical pictures become almost same in both the groups of hysterectomy within three to five years of operation. Hormonal levels also reveal an acute and abrupt change immediately after hysterectomy with BSO but within three to five years, the levels are almost same in both the groups. So basically the internal environment, clinical profile and hormonal mileu assume the same proportion in the two groups within three to five years post-operatively. REFERENCES 1. Te Lindes Operative Gynecology, 9 th Edition Philadelphia. Lippincott Williams & Wilkins (2003). 2. S. Askel and D.W. Schomber, Am. J. Obstet Gynecol 125, 165 (1976). 3. J. Defazio and D. R. Meldru, et al. J. Clin. Enocrinol. Metab 56, 445 (1983). 4. D. H. Richards, A Post Hysterectomy syndrome. Lancet 2, 983 (1974). 5. R. L. Martin and W. V. Roberts, Cayton PJ. Psychiatric Status after Hysterectomy, One Year Follow Up. JAMA 244, 350 (1980). 6. T. B. Perlstein Hormone and Depression, What are the Facts about Premenstrual Syndrome, Menopause and Hormone Replacement Therapy?, Am. J. Obstet. Gynecol., 173, 646 (1995). 7. M. M. Ryan, L. Dennerstein and R. Pepperell Psychological Aspect of Hysterectomy, A Prospective Study. Br. J. Psychol. 154, 516 (1989).

Int. J. Chem. Sci.: 6(3), 2008 1235 8. S. A. Everson and K. A. Matthews, et al. Effects of Surgical Menopause on Lipid Levels and Psychological Characteristic, The Health Women Study, Health Psychol 14, 435 (1995). 9. G. A. Greendale and J. L. Judd The Menopause, Health Implication and Clinical Management J. Am., Geriatr Soc. 41, 426-36 (1993). 10. J. M. Van Geelen, P. H. Van de wejjer and H. T. Arnoldo, Urogenital Symptoms and Resulting Discomfort in Non-institutionalised Dutch Women, Int. Urogynecol. J. Pelvic Floor Dysfunction 11, 9 (2000). 11. G. A. Laughlin, E. Barrett-Connor, et al., J. Clin, Endrocrinol Metab 85, 645 (2000). Accepted : 17.06.2008